Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 B.O.N. Injection in Vitamin D Deficiency
NCT03233295Phase 4Completed
- Sponsor
- Kwang Dong Pharmaceutical Co., Ltd.
- Start
- Oct 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of Vitamin D3 B.O.N in Vitamin D deficiency (VDD), sponsored by Kwang Dong Pharmaceutical Co., Ltd. Primary endpoint: Serum 25-hydroxyvitamin D concentration at 12 months. Started Oct 2014; status: completed.
02
Drugs
Vitamin D3 B.O.N.
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03233295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03233295.